期刊文献+

FLT3-ITD基因阳性急性髓系白血病的免疫表型及临床特征研究

Immunopphenotype and clinical features of acute myeloid leukemia with positive FLT3-ITD
下载PDF
导出
摘要 目的探讨急性髓系白血病(AML)患者FMS样酪氨酸激酶3内部串联重复序列(FLT3-ITD)的免疫表型特征及血小板(PLT)、血红蛋白(Hb)水平等临床指标变化。方法选取广东医科大学附属医院血液内科2016年5月至2018年11月收治的140例AML患者为观察对象,其中FLT3-ITD阳性25例(阳性组),FLT3-ITD阴性115例(阴性组)。回顾性分析AML患者FLT3-ITD阳性及阴性的免疫表型,并观察临床指标特点,同时结合相关文献进行总结分析。结果与阴性组患者比较,阳性组患者免疫表型CD33、CD56、CD7表达率及外周血白细胞计数(WBC)、骨髓白血病细胞占比均明显升高,而CD117表达率明显降低,差异均有统计学意义(P<0.05);但两组患者的Hb及PLT水平比较,差异无统计学意义(P>0.05);阴性组患者的治疗总反应率高于阳性组患者(72.63%vs.40.91%),两组患者治疗总反应率比较差异有统计学意义(P<0.05)。结论AML患者的白血病细胞抗原与FLT3-ITD基因型有关,FLT3-ITD阳性患者的淋系抗原CD56、CD7及髓系抗原CD33均呈高表达,而髓系抗原CD117呈低表达,且治疗缓解率低。 Objective To observe the immunopphenotypic features of FMS-like tyrosine kinease 3-internal tandem duplication(FLT3-ITD)and the changes of clinical indexes,such as platelet(PLT)and hemoglobin(Hb)level,in patients with acute myelogenous leukemia(AML).Methods 140 AML patients admitted to the department of hematology of affiliated hospital of guangdong medical university from May 2016 to November 2018 were selected as the observation objects.Among them,25 cases were positive for FLT3-ITD(the positive group),and 115 cases were negative(the negative group).The immunophenotypes of AML patients with positive FLT3-ITD and negative FLT3-ITD were prospectively analyzed,and the characteristics of clinical indexeswere observed.At the same time,relevant literatures were combined for summary and discussion.Results The expression rates of immunopathotype CD33,CD56 and CD7,white blood cells(WBC)count and proportion of leukemia cells in peripheral blood of FLT3-ITD positive AML patients were higher than those of FLT3-ITD negative AML patients,while the expression rate of CD117 was lower,the differences were statistically significant(P<0.05).However,there was no significant change in Hb and PLT levels(P>0.05).The total response rate in FLT3-ITD negative patients was higher than those in FLT3-ITD positive patients(72.63%vs.40.91%),and the difference was statistically significant(P<0.05).Conclusion Leukemia cell antigen in AML patients is associated with genotype FLT3-ITD.In FLT3-ITD positive patients,lymphoid antigen CD56,CD7 and myeloid antigen CD33 show high expression,while myeloid antigen CD117 shows low expression and low remission rate.
作者 吴国才 杨志刚 李庆华 马境志 WU Guocai;YANG Zhigang;LI Qinghua;MA Jingzhi(Department of Hematology and Rheumatology,Zhanjiang Central People′s Hospital,Zhanjiang,Guangdong 524000,China;Department of Hematology,Affiliated Hospital of Guangdong Medical University,Zhanjiang,Guangdong 524000,China)
出处 《重庆医学》 CAS 2019年第17期2964-2966,2970,共4页 Chongqing medicine
基金 广东省科学技术厅关于下达2014年度省公益研究与能力建设专项资金项目(2014A020212300)
关键词 急性髓系白血病 FMS样酪氨酸激酶3内部串联重复序列 基因型 临床特征 免疫表型 完全缓解率 acute myeloid leukemia FMS-like tyrosine kinease 3-internal tandem duplication genotype clinical features immunophenotype complete response rate
  • 相关文献

参考文献10

二级参考文献94

  • 1玄风华,谢福源.讨论伴t(8;21)的急性髓系白血病的形态学改变[J].实验与检验医学,2007,25(6):634-634. 被引量:3
  • 2苗雨青,陈子兴,何军,岑建农,鲍晓晶,邱桥成.急性髓系白血病M_2亚型患者的预后多因素分析[J].中国血液流变学杂志,2006,16(1):87-89. 被引量:7
  • 3颜灵芝,陈苏宁,梁建英,冯宇峰,岑建农,何军,常伟荣,朱子玲,潘金兰,吴亚芳,薛永权,吴德沛.急性髓系白血病患者NPM1基因突变分析[J].中华血液学杂志,2007,28(5):289-293. 被引量:17
  • 4张之南,沈悌.血液病诊断与疗效标准[M].3版.北京:科学出版社,2007:116-121.
  • 5张之南,沈悌.血液学诊断与疗效标准[M].2版.北京:科学出版社,1998:214-216.
  • 6KAINZ B, HEINTEL D, MARCULESCU R, et al. Variable prog- nostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv (16) [J]. Hematol J, 2002, 3(6):283-289.
  • 7FROHLING S, SCHLENK R F, BREITRUCK J, et al. Prognostic significance of activating FLT3 mutations in younger adults ( 16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm[ J]. Blood, 2002, 100 (13) : 4372 - 4380.
  • 8Reikvam H,Halfield KJ,Kittang AO,et al.Acute Myeloid Leukemia with the t(8;21)Translocation:Clinical Consequences and Biological Implications.Journal of Biomedicine and Biotechnology,2011;1155(10):104631.
  • 9Paschla P,Marcucci G,Ruppert AS,et al.Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16)and t(8;21):a Cancer and Leukemia Group B Study.J Clin Oncol,2006;24(24):3904-3911.
  • 10Schnittger S,Kohl TM,Haferlach T,et al.KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired eventfree and overall survival.Blood,2006;107(5):1791-1799.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部